Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.70
+0.15 (0.61%)
At close: Feb 11, 2026
Market Cap1.78B +32.7%
Revenue (ttm)607.89M +30.6%
Net Income-83.60M
EPS-1.15
Shares Out72.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume194,241
Average Volume230,596
Open24.65
Previous Close24.55
Day's Range24.00 - 24.80
52-Week Range14.30 - 30.00
Beta0.12
RSI47.35
Earnings DateApr 24, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2024, Genomics BioSci & Tech.'s revenue was 482.75 million, an increase of 21.86% compared to the previous year's 396.14 million. Losses were -223.10 million, 32.7% more than in 2023.

Financial Statements